Literature DB >> 26424650

Burkitt's Lymphoma.

Rosemary Rochford1, Ann M Moormann2.   

Abstract

Endemic Burkitt's lymphoma (BL) remains the most prevalent pediatric cancer in sub-Saharan Africa even though it was the first human cancer with a viral etiology described over 50 years ago. Epstein-Barr virus (EBV) was discovered in a BL tumor in 1964 and has since been implicated in other malignancies. The etiology of endemic BL has been linked to EBV and Plasmodium falciparum malaria co-infection. While epidemiologic studies have yielded insight into EBV infection and the etiology of endemic BL, the modulation of viral persistence in children by malaria and deficits in EBV immunosurveillance has more recently been reified. Renewed efforts to design prophylactic and therapeutic EBV vaccines provide hope of preventing EBV-associated BL as well as increasing the ability to cure this cancer.

Entities:  

Mesh:

Year:  2015        PMID: 26424650     DOI: 10.1007/978-3-319-22822-8_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  15 in total

1.  A promiscuous inflammasome sparks replication of a common tumor virus.

Authors:  Eric M Burton; Raphaela Goldbach-Mansky; Sumita Bhaduri-McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-09       Impact factor: 11.205

2.  Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children.

Authors:  Carrie B Coleman; Ibrahim I Daud; Sidney O Ogolla; Julie A Ritchie; Nicholas A Smith; Peter O Sumba; Arlene E Dent; Rosemary Rochford
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

3.  Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.

Authors:  Neelakshi R Jog; Micah T McClain; Latisha D Heinlen; Timothy Gross; Rheal Towner; Joel M Guthridge; Robert C Axtell; Gabriel Pardo; John B Harley; Judith A James
Journal:  J Autoimmun       Date:  2019-09-09       Impact factor: 14.511

Review 4.  Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.

Authors:  Yusuke Kanda; Mitsuhiko Osaki; Futoshi Okada
Journal:  Int J Mol Sci       Date:  2017-04-19       Impact factor: 5.923

Review 5.  The Global Landscape of EBV-Associated Tumors.

Authors:  Claire Shannon-Lowe; Alan Rickinson
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

6.  Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers.

Authors:  Robert Newton; Nazzarena Labo; Katie Wakeham; Vickie Marshall; Romin Roshan; Angela Nalwoga; Ismail Sebina; Lawrence Muhangi; Emily L Webb; Wendell Miley; Rosemary Rochford; Alison M Elliott; Denise Whitby
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

7.  Challenging perspectives on the cellular origins of lymphoma.

Authors:  Tim I M Malcolm; Daniel J Hodson; Elizabeth A Macintyre; Suzanne D Turner
Journal:  Open Biol       Date:  2016-09       Impact factor: 6.411

8.  Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes.

Authors:  Neelakshi R Jog; Eliza F Chakravarty; Joel M Guthridge; Judith A James
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 8.786

9.  SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.

Authors:  Rongrong Zhang; Haiyan Zhu; Yufang Yuan; Yun Wang; Zhaofang Tian
Journal:  Oncol Rep       Date:  2020-09-22       Impact factor: 3.906

10.  Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge.

Authors:  Xinle Cui; Zhouhong Cao; Yuriko Ishikawa; Sara Cui; Ken-Ichi Imadome; Clifford M Snapper
Journal:  Vaccines (Basel)       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.